Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
CytoDyn Inc. (CYDY) had Consolidated Net Income/Loss of $-5.54M for the most recently reported fiscal quarter, ending 2025-08-31.
| Income Statement Financials | |
-- |
|
$-5.91M |
|
-- |
|
-- |
|
$4.95M |
|
$-4.95M |
|
$-0.59M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
$-5.54M |
|
|
Consolidated Net Income/Loss |
$-5.54M |
$-5.54M |
|
$-4.95M |
|
$-4.94M |
|
1.25B |
|
1.25B |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$13.35M |
|
-- |
|
$0.13M |
|
$13.48M |
|
$69.42M |
|
-- |
|
$43.57M |
|
$112.99M |
|
$-99.50M |
|
$-99.50M |
|
$-99.50M |
|
1.26B |
|
| Cash Flow Statement Financials | |
$-2.45M |
|
-- |
|
$-0.12M |
|
$11.90M |
|
$9.33M |
|
$-2.57M |
|
$0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.19 |
|
-- |
|
-- |
|
-- |
|
-0.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
5.57% |
|
5.57% |
|
-41.09% |
|
5.57% |
|
$-0.08 |
|
$-0.00 |
|
$-0.00 |
|